MATERIAL SAFETY DATA SHEET

Similar documents
SAFETY DATA SHEET FDU-PB-22

SAFETY DATA SHEET Cell-Based Assay Horseradish Peroxidase. 1. Identification of the Substance/Mixture and of the Company/Undertaking

SAFETY DATA SHEET MRE-269

SAFETY DATA SHEET N-methyl-2-AI (hydrochloride) Section 2. Hazards Identification

SAFETY DATA SHEET 2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine

SAFETY DATA SHEET EpiTitan Histone Peptide Array

SAFETY DATA SHEET..beta.-catenin (Phospho-Ser33,37) Polyclonal Antibody

SAFETY DATA SHEET Glucose Assay Standard

SAFETY DATA SHEET PD

SAFETY DATA SHEET N-.omega.-hydroxytriacontanoyl-D-erythro-Sphing osine

SAFETY DATA SHEET Sodium Acetate Stock Solution (3 M, ph 5.2)

SAFETY DATA SHEET Acetyl Coenzyme A (sodium salt)

SAFETY DATA SHEET Goat Anti-Rabbit IgG HRP

SAFETY DATA SHEET Potassium Chloride Stock Solution (1 M)

SAFETY DATA SHEET ABC99

SAFETY DATA SHEET Pterostilbene. 1. Identification of the Substance/Mixture and of the Company/Undertaking. 2. Hazards Identification

SAFETY DATA SHEET. Melanocyte-Stimulating Hormone Release-Inhibiting Factor

SAFETY DATA SHEET MJ33 (lithium salt)

SAFETY DATA SHEET Oxyresveratrol. Section 2. Hazards Identification

SAFETY DATA SHEET Palmitic Acid methyl ester

SAFETY DATA SHEET 5-fluoro PB-22 3-carboxyindole metabolite

SAFETY DATA SHEET Urea Standard

SAFETY DATA SHEET..alpha.,.beta.-methylene Adenosine 5'-triphosphate (sodium salt)

SAFETY DATA SHEET Thiol Cysteine Standard

SAFETY DATA SHEET STF Section 2. Hazards Identification

SAFETY DATA SHEET (±)-4-hydroxy Propranolol (hydrochloride)

SAFETY DATA SHEET MPO (human) Control Set. Section 2. Hazards Identification

SAFETY DATA SHEET Acridinium NHS ester

SAFETY DATA SHEET PtdIns-(3,5)-P2 (1,2-dioctanoyl) (sodium salt)

SAFETY DATA SHEET Calcium Standard

SAFETY DATA SHEET Oxymatrine. Section 2. Hazards Identification

SAFETY DATA SHEET AG-18

SAFETY DATA SHEET Cytidine 5'-triphosphate (sodium salt)

SAFETY DATA SHEET Lisdexamfetamine (mesylate) RM

SAFETY DATA SHEET Doramapimod

SAFETY DATA SHEET Telavancin

SAFETY DATA SHEET MI-nc (hydrochloride)

SAFETY DATA SHEET Angiotensin II (human)

SAFETY DATA SHEET Insulin Solution (1,000X)

SAFETY DATA SHEET Human Fibrinogen (PAD2 Citrullinated)

SAFETY DATA SHEET JMJD2E-Strep tagged (human recombinant)

SAFETY DATA SHEET seh Assay Buffer (10X)

SAFETY DATA SHEET. NMDA Receptor NR1 Subunit Monoclonal Antibody

SAFETY DATA SHEET. Brain-Derived Acidic Fibroblast Growth Factor ( ) bovine (trifluoroacetate

SAFETY DATA SHEET AB-PINACA

SAFETY DATA SHEET Dimethyl curcumin

SAFETY DATA SHEET Gly-Phe-.beta.-naphthylamide. Section 2. Hazards Identification

SAFETY DATA SHEET MPO Peroxidation Substrate. Section 2. Hazards Identification

SAFETY DATA SHEET Suc-Leu-Tyr-AMC

SAFETY DATA SHEET AG-825

SAFETY DATA SHEET Palmitic Acid

SAFETY DATA SHEET (±)-Taxifolin. Section 2. Hazards Identification

SAFETY DATA SHEET Stearic Acid methyl ester

SAFETY DATA SHEET Guanosine 3',5 -cyclic monophosphate (sodium salt)

SAFETY DATA SHEET Zeaxanthin

SAFETY DATA SHEET DPP (IV) (human recombinant) Assay Reagent

SAFETY DATA SHEET Ubiquinol

SAFETY DATA SHEET Bufalin. Section 2. Hazards Identification

SAFETY DATA SHEET. Phosphothreonine (Ascites) Monoclonal Antibody (Clone 18F6)

SAFETY DATA SHEET JWH 250. Section 2. Hazards Identification

SAFETY DATA SHEET Nobiletin

M A T E R I A L S A F E T Y D A T A S H E E T

SAFETY DATA SHEET CX Section 2. Hazards Identification

SAFETY DATA SHEET Fenoprofen (calcium salt hydrate)

SAFETY DATA SHEET Lorazepam-13C2-d4 RM. Section 2. Hazards Identification

SAFETY DATA SHEET Dodecylphosphocholine-d38

SAFETY DATA SHEET Everolimus

SAFETY DATA SHEET coumarin-saha. Section 2. Hazards Identification

SAFETY DATA SHEET. Prostaglandin D Synthase (hematopoietic-type) Inhibitor I

SECTION 1. Product and Company Identification TRAP N'TOSS ATTRACTANT. SECTION 2. Composition/Information on Ingredients TRAP N'TOSS ATTRACTANT

SAFETY DATA SHEET MMP-2/MMP-9 Inhibitor III

SAFETY DATA SHEET Tianeptine (sodium salt)

SAFETY DATA SHEET Sumatriptan succinate. Section 2. Hazards Identification

SAFETY DATA SHEET EIA Tracer Dye

SAFETY DATA SHEET Desmethylene Paroxetine (hydrochloride)

SAFETY DATA SHEET PD 98059

SAFETY DATA SHEET Leu-Enkephalin

SAFETY DATA SHEET UltraPure Water

SAFETY DATA SHEET Emtricitabine

SAFETY DATA SHEET PHA Section 2. Hazards Identification

SAFETY DATA SHEET MAB-CHMINACA. Section 2. Hazards Identification

SAFETY DATA SHEET Spiro-MeOTAD

SAFETY DATA SHEET Eptifibatide

SAFETY DATA SHEET. 4-Methylumbelliferyl-a-L-Idopyranosiduronic Acid 2-sulfate (sodium salt)

SAFETY DATA SHEET Azelaic Acid. Section 2. Hazards Identification

SAFETY DATA SHEET Melatonin-d4. Section 2. Hazards Identification

SAFETY DATA SHEET Cyclic AMP. Section 2. Hazards Identification

SAFETY DATA SHEET Ursolic Acid

SAFETY DATA SHEET Terazosin (hydrochloride)

SAFETY DATA SHEET Pyronin Y. Section 2. Hazards Identification

SAFETY DATA SHEET. Tris(4,7-diphenyl-1,10-phenanthroline)ruthenium II dichloride complex

SAFETY DATA SHEET Isoprinosine

SAFETY DATA SHEET PFK-15. Section 2. Hazards Identification

SAFETY DATA SHEET Progesterone-d9. Section 2. Hazards Identification

Transcription:

MSDS: MATERIAL SAFETY DATA SHEET SECTION 1. Chemical Product and Company Identification Product Code: 90230, Reference #: FA Product Name: CAS Number: 1783-84-2 Chemical Family: Fatty Acids Synonyms 8Z,11Z,14Z-eicosatrienoic acid Manufacturer Name and Address: Telephone Numbers: Dates: Cayman Chemical Company Cayman Chemical Company (800)364-9897 Date Entered: 06/27/1996 1180 E. Ellsworth Rd. Revision: 02/13/2002 Ann Arbor, MI. 48108 Cayman Chemical Company (734)971-3335 Printed: 02/14/2002 SECTION 2. Composition/Information on Ingredients Hazardous Components (Specific Chemical Identity/Common Name) CAS # Percentage 1783-84-2 10.0 Ethyl alcohol 64-17-5 90.0 SECTION 3. Hazards Identification Emergency Overview Route(s) of Entry: Inhalation? Yes, Skin? Yes, Eyes? Yes, Ingestion? Yes, Other: Injection Potential Health Effects (Acute and Chronic) Contact may cause skin or eye irritation. Material may be irritating to the mucous membranes and upper respiratory tract. May be harmful by inhalation, ingestion, or skin absorption. The toxicological properties of this compound have not been fully evaluated. Carcinogeniticy: NTP? No, IARC Monographs? No, OSHA Regulated? No Carcinogenicity/Other Information Signs and Symptoms Of Exposure Irritating to the skin, eyes, nose, throat, and respiratory tract. Page 1 of 5

MSDS: SECTION 4. First Aid Measures Emergency and First Aid Procedures If inhaled remove to fresh air. If not breathing, give artificial respiration or give oxygen by trained personnel. Get immediate medical attention. If swallowed, wash out mouth with water provided person is conscious. Never give anything by mouth to an unconscious person. Get medical attention. In case of contact with eyes, hold eyelids apart and flush eyes with plenty of water. After initial flushings, remove any contact lenses and continue flushing for at least 15 minutes. Have eyes examined and tested by medical personnel. In case of skin contact, immediately wash skin with soap and plenty of water. Remove contaminated clothing. Get medical attention if symptoms occur. Wash clothing before reuse. Note to Physician Medical Conditions Generally Aggravated By Exposure SECTION 5. Fire Fighting Measures Flash Pt: Method Used: Explosive Limits: LEL: UEL: Extinguishing Media Use alcohol foam, carbon dioxide, or water spray when fighting fires involving this material. Fire Fighting Instructions As in any fire, wear self-contained breathing apparatus pressure-demand (MSHA/NIOSH approved or equivalent), and full protective gear to prevent contact with skin and eyes. Note: Flammable as diluted in ethanol. Flammable Properties and Hazards Container explosion may occur under fire conditions. Emits toxic fumes under fire conditions. Flammable Liquid. Can release vapors that form explosive mixtures at temperatures at or above the flashpoint. Vapors can travel to a source of ignition and flash back. Hazardous Combustion Products SECTION 6. Accidental Release Measures Steps To Be Taken In Case Material Is Released Or Spilled Absorb spill with inert material (e.g. dry sand or earth), then place in a chemical waste container. After removal, ventilate contaminated area and flush thoroughly with water. SECTION 7. Handling and Storage Hazard Label Information: Avoid contact with skin and eyes. Do not reuse this container. Use with adequate ventilation. Wash thoroughly after handling. Page 2 of 5

MSDS: Precautions To Be Taken in Handling Avoid contact with eyes, skin, and clothing. Do not reuse this container. Use with adequate ventilation. Wash thoroughly after handling. Precautions To Be Taken in Storing Store at correct temperature. Other Precautions Work/Hygienic/Maintenance Practices Do not take internally. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Wash thoroughly after handling. SECTION 8. Exposure Controls/Personal Protection Protective Equipment Summary - Hazard Label Information Eye wash station in work area Lab coat Latex disposable gloves Safety glasses Safety shower in work area Vent Hood Respiratory Equipment (Specify Type) Eye Protection Safety glasses Protective Gloves Latex disposable gloves Other Protective Clothing Engineering Controls (Ventilation etc.) Good general ventilation should be sufficient to control airborne levels. SECTION 9. Physical and Chemical Properties Physical States: [ ] Gas, [ X ] Liquid, [ ] Solid Boiling Point: Melting Point: Specific Gravity (Water = 1): Vapor Pressure (vs. Air or mm Hg): Vapor Density (vs. Air = 1): Evaporation Rate (vs Butyl Acetate=1): Solubility in Water: *100ug/ml Other Solubility Notes: *PBS ph 7.2, sol. in DMF, DMSO, & EtOH Percent Volatile: Molecular Formula: C20H34O2 Molecular Weight: 306.50 ph: Appearance and Odor A clear, colorless solution with a fish-like odor SECTION 10. Stability and Reactivity Page 3 of 5

MSDS: Stability: Unstable [ ] Stable [ X ] Conditions To Avoid - Instability Incompatibility - Materials To Avoid Hazardous Decomposition Or Byproducts Hazardous Polymerization: Will occur [ ] Will not occur [ X ] Conditions To Avoid - Hazardous Polymerization SECTION 11. Toxicological Information The toxicological effects of this compound have not been thoroughly studied. Chronic Toxicological Effects SECTION 12. Ecological Information Data not yet available. SECTION 13. Disposal Considerations Waste Disposal Method Dispose in accordance with local, state and federal regulations. SECTION 14. Transport Information DOT Proper Shipping Name Additional Transport Information Transport in accordance with local, state, and federal regulations. SECTION 15. Regulatory Information The data given here is based on current knowledge and experience. The purpose of this safety data sheet is to describe the products in terms of their safety requirements. The data does not signify any guarantee with regard to the product's properties. Page 4 of 5

MSDS: SECTION 16. Other Information For research use only, not for human or veterinary clinical use. DISCLAIMER: This information is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. Page 5 of 5